178 related articles for article (PubMed ID: 17370041)
1. Expression of the cytoskeleton linker protein ezrin in human cancers.
Bruce B; Khanna G; Ren L; Landberg G; Jirström K; Powell C; Borczuk A; Keller ET; Wojno KJ; Meltzer P; Baird K; McClatchey A; Bretscher A; Hewitt SM; Khanna C
Clin Exp Metastasis; 2007; 24(2):69-78. PubMed ID: 17370041
[TBL] [Abstract][Full Text] [Related]
2. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas.
Sarrió D; Rodríguez-Pinilla SM; Dotor A; Calero F; Hardisson D; Palacios J
Breast Cancer Res Treat; 2006 Jul; 98(1):71-9. PubMed ID: 16538541
[TBL] [Abstract][Full Text] [Related]
3. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of Ezrin and CD44 co‑expression in breast cancer.
Ma L; Jiang T
Oncol Rep; 2013 Oct; 30(4):1899-905. PubMed ID: 23900701
[TBL] [Abstract][Full Text] [Related]
5. Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas.
Carneiro A; Bendahl PO; Åkerman M; Domanski HA; Rydholm A; Engellau J; Nilbert M
J Clin Pathol; 2011 Aug; 64(8):689-94. PubMed ID: 21653656
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer.
Musiał J; Sporny S; Nowicki A
Pol J Pathol; 2007; 58(4):235-43. PubMed ID: 18459457
[TBL] [Abstract][Full Text] [Related]
7. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
8. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
[TBL] [Abstract][Full Text] [Related]
10. Ezrin expression in tissue microarray of primary and recurrent gliomas.
Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.
Weng WH; Ahlén J; Aström K; Lui WO; Larsson C
Clin Cancer Res; 2005 Sep; 11(17):6198-204. PubMed ID: 16144921
[TBL] [Abstract][Full Text] [Related]
12. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
[TBL] [Abstract][Full Text] [Related]
13. Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma.
Köbel M; Gradhand E; Zeng K; Schmitt WD; Kriese K; Lantzsch T; Wolters M; Dittmer J; Strauss HG; Thomssen C; Hauptmann S
Int J Gynecol Pathol; 2006 Apr; 25(2):121-30. PubMed ID: 16633060
[TBL] [Abstract][Full Text] [Related]
14. [Expression of Ezrin in gastric carcinoma and its significance].
Shi RL; Li JF; Qu Y; Chen XH; Gu QL; Zhu ZG; Liu BY
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):433-5. PubMed ID: 17043968
[TBL] [Abstract][Full Text] [Related]
15. The expression and phosphorylation of ezrin and merlin in human pancreatic cancer.
Zhou J; Feng Y; Tao K; Su Z; Yu X; Zheng J; Zhang L; Yang D
Int J Oncol; 2014 Jun; 44(6):2059-67. PubMed ID: 24728215
[TBL] [Abstract][Full Text] [Related]
16. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma.
Chiappetta C; Leopizzi M; Censi F; Puggioni C; Petrozza V; Rocca CD; Di Cristofano C
Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):162-70. PubMed ID: 24614149
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of ezrin in non--small-cell lung cancer.
Zhang XQ; Chen GP; Wu T; Yan JP; Zhou JY
Clin Lung Cancer; 2012 May; 13(3):196-204. PubMed ID: 22137559
[TBL] [Abstract][Full Text] [Related]
19. Similar expression pattern of NHERF1 and EZRIN in papillary but not in solid areas of human serous ovarian carcinomas.
Demacopulo B; Lema BE; Cabrini RL; Kreimann EL
Acta Histochem; 2016 Oct; 118(8):797-805. PubMed ID: 27823775
[TBL] [Abstract][Full Text] [Related]
20. Proteome analysis and tissue array for profiling protein markers associated with type B thymoma subclassification.
Sun QL; Fang WT; Feng J; Zhang J; Yang XH; Gu ZT; Zhu L; Sha HF
Chin Med J (Engl); 2012 Aug; 125(16):2811-8. PubMed ID: 22932072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
